Return to search

Endovalve Seeking $8 Million

Endovalve Inc., a Princeton, N.J.-based developer of a percutaneous valve-replacement system to treat mitral regurgitation, is looking to raise $8 million in Series B funding. It previously raised $2.5 million in first round funding from Battelle Ventures and its affiliate fund Innovation Valley Partners. Battelle has committed up to $3 million for the Series B deal.